Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Ordinary Shares, nominal value 0.05 GBP per share
-
Shares outstanding
-
84,213,667
-
Total 13F shares
-
66,961,392
-
Share change
-
-637,730
-
Total reported value
-
$1,084,932,320
-
Put/Call ratio
-
105%
-
Price per share
-
$16.09
-
Number of holders
-
113
-
Value change
-
-$17,301,242
-
Number of buys
-
57
-
Number of sells
-
46
Institutional Holders of Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) as of Q1 2024
As of 31 Mar 2024,
Verona Pharma plc - Ordinary Shares, nominal value 0.05 GBP per share (VRNA) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,961,392 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., NEA Management Company, LLC, WELLINGTON MANAGEMENT GROUP LLP, PERCEPTIVE ADVISORS LLC, Vivo Capital, LLC, ORBIMED ADVISORS LLC, Deep Track Capital, LP, Frazier Life Sciences Management, L.P., Carlyle Group Inc., and Octagon Capital Advisors LP.
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.